Home » Authors » Mark Lawson

Articles by Mark Lawson

Alchemia Raises A$15.2M To Expand Research, U.S. Operation

April 4, 2001

Alchemia Raises A$15.2M To Expand Research, U.S. Operation

April 4, 2001

PanBio Seeks A$12M In IPO To Fund Diagnostic Programs

Feb. 28, 2001

PanBio Seeks A$12M In IPO To Fund Diagnostic Programs

Feb. 28, 2001

Medica Strengthens Position With Kinase-Targeting Filings

Feb. 14, 2001

Medica Strengthens Position With Kinase-Targeting Filings

Feb. 14, 2001

Analytica Capitalizes On Taiwan Initiative Through New Subsidiary

Feb. 7, 2001

Analytica Capitalizes On Taiwan Initiative Through New Subsidiary

Feb. 7, 2001

Biotran Completes Australian IPO To Fund Diagnostics, HIV Product

Jan. 24, 2001

Biotran Completes Australian IPO To Fund Diagnostics, HIV Product

Jan. 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...